🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Using Retrograde Intrarenal Surgery for Managing Staghorn Renal Stones.

RecruitingNAAges 18 Years - 70 YearsAllHelwan University
NCT07342361 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective, randomized study is comparing the safety and efficacy of using two types of ureteral access sheaths in managing staghorn renal stones by retrograde intrarenal surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adult patients of both sexes. * Patient has a staghorn renal stone (complete or partial staghorn). * Normal renal function tests. * Congenital renal anomalies as horseshoe, pelvic or mal-rotated kidneys. Exclusion Criteria: * Abnormal coagulation profile. * Active or untreated urinary tract infection. * Age under 18 years or above 70 years. * Patient has a staghorn stone associated with other pathology which requires additional intervention, as ureteral stricture or ureteropelvic junction obstruction (UPJO). * Pregnancy.
💊

What it tests

  • Retrograde intrarenal surgery
📍

Where

1 site
Faculty of medicine, Helwan University
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy